Abstract 60: Heparan sulfate proteoglycans can mediate cancer cell oriented migration through integrin independent Rac 1 activation

Abstract Cancer cell membranes and tumor associated extracellular matrix are characterized by a predominant presence of highly sulfated Heparan Sulfate Proteoglycans (HSPGs), which have already been identified as potential tumor markers in different cancers. We previously reported on stable tetra-br...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 79; no. 13_Supplement; p. 60
Main Authors Bracci, Luisa, Depau, Lorenzo, Brunetti, Jlenia, Riolo, Giulia, Mandarini, Elisabetta, Zanchi, Marta, Zevolini, Fabrizia, Pini, Alessandro, Falciani, Chiara
Format Journal Article
LanguageEnglish
Published 01.07.2019
Online AccessGet full text

Cover

Loading…
Abstract Abstract Cancer cell membranes and tumor associated extracellular matrix are characterized by a predominant presence of highly sulfated Heparan Sulfate Proteoglycans (HSPGs), which have already been identified as potential tumor markers in different cancers. We previously reported on stable tetra-branched peptides named NT4, which selectively bind different human cancer tissues and cells, thanks to their high affinity binding to sulfated glycosaminoglycans (GAGs). Using drug-conjugated NT4 peptides as selective tumor targeting agents, we obtained a significant reduction in tumor growth, compared with animals treated with the unconjugated drug under identical conditions. Drug-conjugated NT4 can also by-pass drug resistance mediated by membrane transporters (1-8). Besides being potential tumor markers, HSPG are also interesting potential drug targets since they appear to take part in many crucial events of cancer progression, such as epithelial mesenchymal transition, migration and invasion. We identified a putative sulfated oligosaccharide motif allowing high-affinity binding of NT4 to sulfated GAGs. NT4 was then used as a specific tool to analyze the role of sulfated GAGs in signaling events regulating oriented cancer cell migration. NT4 binding exerts different effects on adhesion and migration in different cancer cells. In PANC-1 human pancreatic adenocarcinoma cells, NT4 binding to sulfated GAGs abolishes cell adhesion and dramatically affects directional migration, inducing disorganization of actin filaments and stress fibers and increasing the number filopodia. This occurs without any effect on activation of beta1 integrins or focal adhesion kinase, but with a clear reduction in Rac1 activity. Otherwise, in TE-671 human rhabdomyosarcoma cells, binding of NT4 to sulfated GAGs has little effect on cell adhesion and cell migration. Untreated TE671 have a slow and scarcely oriented migration and a general morphology which recalls that assumed by PANC-1 upon treatment with NT4, with many filopodia and scarcely organized stress fibers. Interestingly, activated Rac1 is not detectable in untreated migrating TE671 cells. PANC-1 and TE671 have a very different expression of syndecans, particularly syndecan 2 and syndecan 4. Our results suggest that HSPGs can work as primary players in directional cell migration and actin filaments assembly, by regulating Rac1 activity through an integrin-independent signaling pathway, which seems to require the expression of syndecan 4. 1. Falciani C et al Mol. Cancer Ther. 2007; 6:2441−2448. 2. Falciani C et al ChemMedChem. 2010; 5:567−574. 3. Falciani C et al Curr. Cancer Drug Targets. 2010; 10:695−704. 4. Falciani C et a. ChemMedChem. 2011; 6:678−685. 5. Falciani C et al J Med Chem. 2013; 56:5009-18. 6. Brunetti J et al Sci Rep. 2016; 6:27174. 7. Brunetti J et al Sci Rep. 2015; 5:17736. 8. Depau L et al Oncotarget. 2017; 8:76141-76152. Note: This abstract was not presented at the meeting. Citation Format: Luisa Bracci, Lorenzo Depau, Jlenia Brunetti, Giulia Riolo, Elisabetta Mandarini, Marta Zanchi, Fabrizia Zevolini, Alessandro Pini, Chiara Falciani. Heparan sulfate proteoglycans can mediate cancer cell oriented migration through integrin independent Rac 1 activation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 60.
AbstractList Abstract Cancer cell membranes and tumor associated extracellular matrix are characterized by a predominant presence of highly sulfated Heparan Sulfate Proteoglycans (HSPGs), which have already been identified as potential tumor markers in different cancers. We previously reported on stable tetra-branched peptides named NT4, which selectively bind different human cancer tissues and cells, thanks to their high affinity binding to sulfated glycosaminoglycans (GAGs). Using drug-conjugated NT4 peptides as selective tumor targeting agents, we obtained a significant reduction in tumor growth, compared with animals treated with the unconjugated drug under identical conditions. Drug-conjugated NT4 can also by-pass drug resistance mediated by membrane transporters (1-8). Besides being potential tumor markers, HSPG are also interesting potential drug targets since they appear to take part in many crucial events of cancer progression, such as epithelial mesenchymal transition, migration and invasion. We identified a putative sulfated oligosaccharide motif allowing high-affinity binding of NT4 to sulfated GAGs. NT4 was then used as a specific tool to analyze the role of sulfated GAGs in signaling events regulating oriented cancer cell migration. NT4 binding exerts different effects on adhesion and migration in different cancer cells. In PANC-1 human pancreatic adenocarcinoma cells, NT4 binding to sulfated GAGs abolishes cell adhesion and dramatically affects directional migration, inducing disorganization of actin filaments and stress fibers and increasing the number filopodia. This occurs without any effect on activation of beta1 integrins or focal adhesion kinase, but with a clear reduction in Rac1 activity. Otherwise, in TE-671 human rhabdomyosarcoma cells, binding of NT4 to sulfated GAGs has little effect on cell adhesion and cell migration. Untreated TE671 have a slow and scarcely oriented migration and a general morphology which recalls that assumed by PANC-1 upon treatment with NT4, with many filopodia and scarcely organized stress fibers. Interestingly, activated Rac1 is not detectable in untreated migrating TE671 cells. PANC-1 and TE671 have a very different expression of syndecans, particularly syndecan 2 and syndecan 4. Our results suggest that HSPGs can work as primary players in directional cell migration and actin filaments assembly, by regulating Rac1 activity through an integrin-independent signaling pathway, which seems to require the expression of syndecan 4. 1. Falciani C et al Mol. Cancer Ther. 2007; 6:2441−2448. 2. Falciani C et al ChemMedChem. 2010; 5:567−574. 3. Falciani C et al Curr. Cancer Drug Targets. 2010; 10:695−704. 4. Falciani C et a. ChemMedChem. 2011; 6:678−685. 5. Falciani C et al J Med Chem. 2013; 56:5009-18. 6. Brunetti J et al Sci Rep. 2016; 6:27174. 7. Brunetti J et al Sci Rep. 2015; 5:17736. 8. Depau L et al Oncotarget. 2017; 8:76141-76152. Note: This abstract was not presented at the meeting. Citation Format: Luisa Bracci, Lorenzo Depau, Jlenia Brunetti, Giulia Riolo, Elisabetta Mandarini, Marta Zanchi, Fabrizia Zevolini, Alessandro Pini, Chiara Falciani. Heparan sulfate proteoglycans can mediate cancer cell oriented migration through integrin independent Rac 1 activation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 60.
Author Falciani, Chiara
Bracci, Luisa
Mandarini, Elisabetta
Zanchi, Marta
Riolo, Giulia
Depau, Lorenzo
Brunetti, Jlenia
Zevolini, Fabrizia
Pini, Alessandro
Author_xml – sequence: 1
  givenname: Luisa
  surname: Bracci
  fullname: Bracci, Luisa
– sequence: 2
  givenname: Lorenzo
  surname: Depau
  fullname: Depau, Lorenzo
– sequence: 3
  givenname: Jlenia
  surname: Brunetti
  fullname: Brunetti, Jlenia
– sequence: 4
  givenname: Giulia
  surname: Riolo
  fullname: Riolo, Giulia
– sequence: 5
  givenname: Elisabetta
  surname: Mandarini
  fullname: Mandarini, Elisabetta
– sequence: 6
  givenname: Marta
  surname: Zanchi
  fullname: Zanchi, Marta
– sequence: 7
  givenname: Fabrizia
  surname: Zevolini
  fullname: Zevolini, Fabrizia
– sequence: 8
  givenname: Alessandro
  surname: Pini
  fullname: Pini, Alessandro
– sequence: 9
  givenname: Chiara
  surname: Falciani
  fullname: Falciani, Chiara
BookMark eNo9kN1KAzEQhYNUsK0-gTd5ga353R_vSlErVATp_ZJNZreRbbIkqdBrX9xdK96cOXNmmIFvgWbOO0DonpIVpbJ8oJKXWSGEXK3fGKFVlpMrNP9PZ2hOCCkzKQp2gxYxfo6tpETO0fe6iSkonXBOHvEWBhWUw_HUtyoBHoJP4Lv-rJWLeBR8BGOnyeg1BKyh77EPFlwCg4-2CypZ73A6BH_qDtiOeResG42BAUZxCX8ojSkef9qv3-1bdN2qPsLdX12i_fPTfrPNdu8vr5v1LtNlRTImtFCgdMGLHJiqKto0TDScAaeiBdkaSYxocsOINqCgkLQt88oQXkktteBLxC9ndfAxBmjrIdijCueaknrCWE_A6glYfcFY54T_ALUDamo
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1158/1538-7445.AM2019-60
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1538-7445
EndPage 60
ExternalDocumentID 10_1158_1538_7445_AM2019_60
GroupedDBID ---
-ET
18M
29B
2WC
34G
39C
476
53G
5GY
5RE
5VS
6J9
AAYXX
ABOCM
ACGFO
ACIWK
ACPRK
ACSVP
ADBBV
ADCOW
ADNWM
AENEX
AFHIN
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
EBS
EJD
F5P
FRP
GX1
H13
IH2
KQ8
L7B
LSO
OK1
P0W
P2P
PQQKQ
RCR
RHF
RHI
RNS
SJN
TR2
W2D
W8F
WH7
WOQ
YKV
YZZ
ID FETCH-LOGICAL-c890-24c4aeac7376e2a991bb24b32e314fe5fd50d4b6d20cdeae751f869d0395c5c43
ISSN 0008-5472
IngestDate Thu Sep 26 17:50:45 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 13_Supplement
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c890-24c4aeac7376e2a991bb24b32e314fe5fd50d4b6d20cdeae751f869d0395c5c43
OpenAccessLink https://doi.org/10.1158/1538-7445.am2019-60
PageCount 1
ParticipantIDs crossref_primary_10_1158_1538_7445_AM2019_60
PublicationCentury 2000
PublicationDate 2019-07-01
PublicationDateYYYYMMDD 2019-07-01
PublicationDate_xml – month: 07
  year: 2019
  text: 2019-07-01
  day: 01
PublicationDecade 2010
PublicationTitle Cancer research (Chicago, Ill.)
PublicationYear 2019
SSID ssj0005105
Score 2.3438127
Snippet Abstract Cancer cell membranes and tumor associated extracellular matrix are characterized by a predominant presence of highly sulfated Heparan Sulfate...
SourceID crossref
SourceType Aggregation Database
StartPage 60
Title Abstract 60: Heparan sulfate proteoglycans can mediate cancer cell oriented migration through integrin independent Rac 1 activation
Volume 79
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuK57iLR-4hRQ3cZyUW3mpLCoHVKS9RbHj7FYKCeomSOyVn8gfYsaPJMAKsVys1kqnTubTjMf5ZoaQp7Cl0GAZo5CVUQUBimBhJnkZIl5SnemCZ5jvvPkg1p_40XFyPJv9mLCW-k7O1fmFeSX_o1WYA71iluwlNDsIhQn4DPqFETQM4z_peCXxoEJ1gWAY2a81FvJukHFewRYyMDUY2pP6Gzw-rEHd2DyRzlC9lN4HeGoftFjpGPedn3cnDg6-eY-tJbFDMqRvltsFHwsVLEwNjq-jVsdaByjXVRA6Na-ILdfD2KK6nk9OHl7C0pVNzu53Z4N7eA130ZvZdq-b83a8vG90Z9kHRzVyBIeXRZhyYw74d33tpt1Bhsmd8gcZ3jhnYcJtJ5-5Hu1xym3FSW-wbfcZD8w4N_1PR6KQtcS2S4Hz6fbLn94iwQyI4T_mq41Zl__ptDb3bz5zYDKaGCrJchSSo5DcCskFu0KuRmD9DHfg3fuRd-R4tf5uXSksEPL8gpVMtkuTfc_2Bjl0AQtdWfTdJDPd3CLXNo6ScZt89yCkgr2gDoLUQZD-AkEKA3UQpBaCFCFIPQTpAEHqIEg9BOkEghQgSBd0hOAdsn37ZvtqHbrOHqHKliyMuOIFePwUvJuOCghRpIy4jCMdL3ilk6pMWMmlKCOmSl3oNFlUmViWLF4mKlE8vksOmrbR9wjNhJCsKmIhITCWUkMUVvAFJoRjbpxK75Nn_vnlX2z9lvwvOntwucsfkusjkh-Rg27f68ewSe3kE6P0n8xxkDc
link.rule.ids 315,783,787,27936,27937
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abstract+60%3A+Heparan+sulfate+proteoglycans+can+mediate+cancer+cell+oriented+migration+through+integrin+independent+Rac+1+activation&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Bracci%2C+Luisa&rft.au=Depau%2C+Lorenzo&rft.au=Brunetti%2C+Jlenia&rft.au=Riolo%2C+Giulia&rft.date=2019-07-01&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=79&rft.issue=13_Supplement&rft.spage=60&rft.epage=60&rft_id=info:doi/10.1158%2F1538-7445.AM2019-60&rft.externalDBID=n%2Fa&rft.externalDocID=10_1158_1538_7445_AM2019_60
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon